Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Chris K. Neeley"'
Autor:
Robert D. Loberg, LaShon L. Day, Jason Harwood, Chi Ying, Lauren N. St. John, Ryan Giles, Chris K. Neeley, Kenneth J. Pienta
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 8, Iss 7, Pp 578-586 (2006)
Tumor cells in the bone interact with the microenvironment to promote tumor cell survival and proliferation, resulting in a lethal phenotype for patients with advanced prostate cancer. Monocyte chemoattractant protein 1 (CCL2) is a member of the CC c
Externí odkaz:
https://doaj.org/article/63fdaa01616f49b1a2db1f9c3d3d19a0
Autor:
Russell S. Taichman, James R. Baker, Jacques E. Nör, Paul H. Krebsbach, Kenneth J. Pienta, Chris K. Neeley, Jin Koo Kim, Elliott Hill, Younghun Jung
Publikováno v:
Journal of cellular biochemistry, vol 119, iss 10
Therapeutic strategies targeting both cancer cells and associated cells in the tumor microenvironment offer significant promise in cancer therapy. We previously reported that generation 5 (G5) dendrimers conjugated with cyclic-RGD peptides target cel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7423eee8f739fa661ec85b9f63c453a
https://escholarship.org/uc/item/20s2x0dc
https://escholarship.org/uc/item/20s2x0dc
Autor:
Alnawaz Rehemtulla, Linda A. Snyder, Craig J. Galbán, Thomas L. Chenevert, Sudha Sud, Kenneth J. Pienta, Chris K. Neeley, Stefan Rozel, Kuei C. Lee, Brian D. Ross, Klaas Nicolay
Publikováno v:
Journal of Cellular Biochemistry, 107(1), 58-64. Wiley-Liss Inc.
Metastatic prostate cancer continues to be the second leading cause of cancer death in American men with an estimated 28,660 deaths in 2008. Recently, monocyte chemoattractant protein-1 (MCP-1, CCL2) has been identified as an important factor in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e29864f9a7a05d0d9d9206843c8fc92
https://doi.org/10.1002/jcb.22056
https://doi.org/10.1002/jcb.22056
Autor:
Chris K. Neeley, Matthew J. Craig, Robert D. Loberg, Kwanchanit Tantivejkul, Kenneth J. Pienta
Publikováno v:
Journal of Cellular Biochemistry. 101:1292-1300
Patients with advanced prostate cancer often exhibit increased activation of the coagulation system. The key activator of the coagulation cascade is the serine protease thrombin which is capable of eliciting numerous cellular responses. We previously
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13bab3004a810ff51868eb04a14a508d
https://doi.org/10.1002/jcb.21252
https://doi.org/10.1002/jcb.21252
Autor:
Ryan Giles, Jason Harwood, La Shon L. Day, Kenneth J. Pienta, Chi Ying, Robert D. Loberg, Lauren N. St. John, Chris K. Neeley
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 8, Iss 7, Pp 578-586 (2006)
Tumor cells in the bone interact with the microenvironment to promote tumor cell survival and proliferation, resulting in a lethal phenotype for patients with advanced prostate cancer. Monocyte chemoattractant protein 1 (CCL2) is a member of the CC c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88c4fda989930152bb02f1860a32aa86
http://www.sciencedirect.com/science/article/pii/S1476558606800138
http://www.sciencedirect.com/science/article/pii/S1476558606800138
Prostate epithelial cell growth is dependent on the presence of androgens, and transition of prostate cancer to an androgen-independent phenotype results in a highly aggressive, currently incurable cancer. We have developed a new preclinical model of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6481b3c32b6ed49e98654a2784a6d9a
https://europepmc.org/articles/PMC1557359/
https://europepmc.org/articles/PMC1557359/
Publikováno v:
Biochemical Education. 25:233-235
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::de8dd3a8c91369169e6f71d44566ea66
https://doi.org/10.1016/s0307-4412(97)00122-2
https://doi.org/10.1016/s0307-4412(97)00122-2
Autor:
Chris K. Neeley, Lashon L. Adam-Day, Kenneth J. Pienta, Sheri Nixdorf, Lauren N. St. John, Paul Jackson, Robert D. Loberg, Yaron Fridman, Linda M. Kalikin
Publikováno v:
International Journal of Oncology.
We previously identified MIM-A (missing in metastasis, MTSS1) by differential display techniques as missing in invasive, metastatic bladder cancer cell lines and suggested that MIM-A is a novel putative metastasis suppressor gene. Characterization of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5e4d2d7ae226c819988d9da988e8ce27
https://doi.org/10.3892/ijo.26.6.1699
https://doi.org/10.3892/ijo.26.6.1699
Autor:
Robert D, Loberg, Chris K, Neeley, Lashon L, Adam-Day, Yaron, Fridman, Lauren N, St John, Sheri, Nixdorf, Paul, Jackson, Linda M, Kalikin, Kenneth J, Pienta
Publikováno v:
International journal of oncology. 26(6)
We previously identified MIM-A (missing in metastasis, MTSS1) by differential display techniques as missing in invasive, metastatic bladder cancer cell lines and suggested that MIM-A is a novel putative metastasis suppressor gene. Characterization of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::168361b04594dcf815df0a5b2ae7e59b
https://pubmed.ncbi.nlm.nih.gov/15870888
https://pubmed.ncbi.nlm.nih.gov/15870888
Autor:
Linda M. Kalikin, Gerald V. Doyle, Rodney L. Dunn, Robert D. Loberg, Bert T. Chen, S.M. O’Hara, Kenneth J. Pienta, Steve Gross, Chris K. Neeley
Publikováno v:
Urology. 65(3)
Objectives To enumerate the amount of circulating tumor cells (CTCs) in patients with advanced prostate cancer and to investigate the relationship between these numbers, prostate-specific antigen (PSA) and prostate-specific membrane antigen (PSM) exp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf999638010acab36f6b376cf320d8e4
https://pubmed.ncbi.nlm.nih.gov/15780403
https://pubmed.ncbi.nlm.nih.gov/15780403